Patients (N=223) | Clinical experts (N=63) | Policymakers (N=67) | ||||
---|---|---|---|---|---|---|
Criteria | Coefficient* | SE | Coefficient* | SE | Coefficient* | SE |
Stroke | 0.026 | 0.004 | 0.050 | 0.009 | 0.049 | 0.009 |
MI | 0.021 | 0.002 | 0.037 | 0.004 | 0.042 | 0.004 |
Myalgia | −0.041 | 0.004 | −0.061 | 0.008 | −0.044 | 0.007 |
Hepatotoxicity | −0.308 | 0.020 | −0.367 | 0.043 | −0.368 | 0.041 |
L-L0 | −1426.439 | −406.292 | −433.501 | |||
Pseudo R2† | 0.176 | 0.286 | 0.284 | |||
Number of observations‡ | 4014 | 1134 | 1206 |
*Coefficient with p<0.001.
†McFadden's pseudo R2.
‡Numbers of observations for each stakeholder group.
L-L0, log-likelihood; MI, myocardial infarction.